financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Metro Bancorp's Q3 profit up 69% on higher interest income
US Metro Bancorp's Q3 profit up 69% on higher interest income
Oct 24, 2025
Overview * US Metro Bancorp Q3 net income rises 69% yr/yr to $2.9 mln * EPS for Q3 2025 increases to $0.18 from $0.11 yr/yr * Company reports 13.2% increase in total assets to $1.57 bln Outlook * US Metro Bancorp did not provide specific future guidance Result Drivers * NET INTEREST INCOME - Co reports a year-to-date increase in...
Santee Cooper moves forward with Brookfield to complete nuclear reactors
Santee Cooper moves forward with Brookfield to complete nuclear reactors
Oct 24, 2025
Oct 24 (Reuters) - Public utility company Santee Cooper said on Friday it has approved a letter of intent from Brookfield Asset Management ( BAM ) to enter into talks over resuming construction of two AP1000 nuclear reactors in Fairfield County, South Carolina. Both the companies will initiate a six-week feasibility period during which they will select a project manager,...
US FDA approves Bayer's menopause relief drug
US FDA approves Bayer's menopause relief drug
Oct 24, 2025
(Reuters) -Germany's Bayer said on Friday the U.S. health regulator has approved its drug for menopause relief. The drug, branded as Lynkuet, is a non-hormonal treatment designed to relieve moderate-to-severe vasomotor symptoms, also known as hot flashes, associated with menopause. The U.S. Food and Drug Administration's approval was based on three late-stage studies that showed Lynkuet reduced the frequency and...
US FDA approves Bayer's menopause relief drug
US FDA approves Bayer's menopause relief drug
Oct 24, 2025
Oct 24 (Reuters) - Germany's Bayer said on Friday the U.S. Food and Drug Administration has approved its drug for menopause relief. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved